雲頂新耀-B(1952.HK)配售結果出爐 今日登陸暗盤
格隆匯10月8日丨雲頂新耀-B(1952.HK)公佈,香港公開發售股份共接獲308,757份有效申請,認購合共4,158,771,500股,超購約654.4倍,國配超購27倍。甲組認購倍數355倍,乙組認購倍數954倍。一手(500股)申請份數為197,493份,中籤率為2%,80手穩中一手。發售價為每股發售股份55港元。根據中籤結果,乙頭需申請200手,獲配2手;甲尾申請180手獲配1手並有89.8%的機率獲配2手。共有144個頂頭槌,各中10手。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.